San Mateo, CA, United States of America

Stephen R Carlson

This inventor holds 1 USPTO granted patent. Top assignee: Allergan, Inc.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephen R Carlson. Retrieved from https://idiyas.com/inventor/stephen-r-carlson-22dti76s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephen R. Carlson

Introduction

Stephen R. Carlson is a notable inventor based in San Mateo, California. He has made significant contributions to the field of medical treatments, particularly in the area of neurotoxins. His work has led to advancements that benefit patients suffering from various conditions.

Latest Patents

Stephen R. Carlson holds 1 patent related to botulinum toxin treatments. His patent describes a method and composition for treating patients suffering from diseases, disorders, or conditions associated with pain. The treatment involves administering a therapeutically effective amount of a neurotoxin selected from a group that includes Botulinum toxin types A, B, C, D, E, F, and G.

Career Highlights

Stephen is currently associated with Allergan, Inc., a company known for its innovative approaches in the pharmaceutical industry. His work at Allergan has allowed him to focus on developing effective treatments that improve patient outcomes.

Collaborations

Throughout his career, Stephen has collaborated with notable colleagues, including K Roger Aoki and Michael W. Grayston. These collaborations have contributed to the advancement of his research and the successful development of his patented treatments.

Conclusion

Stephen R. Carlson's contributions to the field of neurotoxin treatments highlight his innovative spirit and dedication to improving healthcare. His work continues to impact the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…